相关实验视频

Updated: Jun 1, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

低甲基化剂作为三阴性乳腺癌的新兴治疗方法

Nik Mohd Asri Nik Amirah Auni¹, Norhanani Mohd Redzwan¹, Agustine Nengsih Fauzi²

¹Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.

|January 17, 2025

概括

低甲基化剂 (HMA) 在通过逆转表观遗传沉默和增强抗瘤免疫力来治疗侵袭性三阴性乳腺癌 (TNBC) 中表现有前途. 需要进一步的研究来优化它们的使用和组合,以获得更好的TNBC结果.

科学领域:

在瘤学瘤学.
癌症表观遗传学癌症表观遗传学
免疫学免疫学免疫学

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有攻击性的亚型,其特点是表观遗传改变.
DNA甲基转移酶 (DNMTs) 通过表观遗传沉默驱动TNBC瘤发生.
低甲基化剂 (HMA) 抑制DNMTs,并具有免疫性质.

研究的目的:

审查TNBC中HMAs的疗效.
讨论TNBC中HMAs诱导的抗瘤免疫反应.
评估HMA在TNBC治疗中的潜力.

主要方法:

在TNBC中对HMA进行临床前和临床研究的文献综述.
对HMAs所针对的表观遗传机制的分析.
评估与HMA治疗相关的免疫反应.

主要成果:

过度表达DNMTs与TNBC的预后不佳相关.
HMAs可以逆转瘤抑制基因的表观遗传沉默.
HMAs增强了TNBC细胞的免疫识别,并在早期试验中证明了安全性.

结论:

通过调节表观遗传学和免疫力,HMA为TNBC提供了潜在的治疗策略.
临床前数据,特别是对瓜迪西塔的数据,支持HMA的有效性.
进一步的临床研究对于优化TNBC的HMA剂量和组合疗法至关重要.

关键词:

亚扎西蒂丁是一种阿扎西蒂丁.德西塔类药物德西塔类药物瓜德西塔是什么药物瓜德西塔低甲基化剂是一种低甲基化剂.免疫治疗是一种免疫疗法.三阴性乳腺癌是三阴性乳腺癌.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...